MIRA INFORM REPORT

 

 

Report Date :

18.07.2013

 

IDENTIFICATION DETAILS

 

Name :

AGIO PHARMACEUTICALS LIMITED

 

 

Registered Office :

A-38, Nandjyot Industrial Estate, Kurla Andheri Road, Safedpool, Andheri (East), Mumbai – 400072, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

24.01.1992

 

 

Com. Reg. No.:

11-065031

 

 

Capital Investment / Paid-up Capital :

Rs. 51.848 Millions

 

 

CIN No.:

[Company Identification No.]

U24239MH1992PLC065031

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMM20995C

 

 

PAN No.:

[Permanent Account No.]

 

 

AABCA8426A

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Prescription Drugs.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1669700

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record. Trade relations are reported to be fair. Business is active. Payments are reported to be usually correct and as per commitments. 

 

The company can be considered for normal business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: CRISIL has suspended its rating due to lack of information. 1

Date

March 2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered/ Marketing & Administrative Office :

A-38, Nandjyot Industrial Estate, Kurla Andheri Road, Safedpool, Andheri (East), Mumbai – 400072, Maharashtra, India

Tel. No.:

91-22-40984545/ 28518206/  42319000

Fax No.:

91-22-28518204

E-Mail :

sdarjee@agio-pharma.com

agio@agio-pharma.com

Website :

www.agio-pharma.com

 

 

Corporate Office :

Mittal Towers, C - Wing 113, 11th Floor, Nariman Point, Mumbai - 400021, Maharashtra, India

Tel. No.:

91-22-22826885/ 42320000

Fax No.:

91-22-22826885

E-Mail :

agio@agio-pharma.com

 

 

Factory :

82, M.I.D.C, Bhosari, Pune – 411026, Maharashtra, India

Tel. No.:

91-20-40730000/ 30683366/ 30683367

Fax No.:

91-20-40730002

E-Mail :

agiopune@agio-pharma.com

 

 

Branch Offices :

Located at:

 

¯      Moscow, Russia

¯      Tashkent, Uzbekistan

¯      Kiev, Ukraine

¯      Almaty, Kazakistan

 

 

DIRECTORS

 

AS ON 29.09.2012

 

Name :

Mr. Madhusudan Ruia

Designation :

Managing director

Address :

10th Floor, Shivam Apartment, Near Babulnath Temple, Grant Road (West), Mumbai – 400007, Maharashtra, India

Date of Birth/Age :

19.08.1957

Qualification :

B. Com

Date of Appointment :

24.01.1992

PAN No.:

AAAPR6008D

DIN No.:

00018971

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH1992PLC065031

AGIO PHARMACEUTICALS LIMITED

Managing director

24/01/1992

24/01/1992

-

Active

NO

2

U24230MH1998PTC117547

SHREE FLEX PRINT PRIVATE LIMITED

Director

01/11/2000

01/11/2000

-

Active

NO

3

U65920MH1985PTC037699

IRIS PROPERTIES PRIVATE LIMITED

Director

11/06/2002

11/06/2002

-

Amalgamated

NO

4

U24230MH1996PTC096954

REVIVE PHARMACEUTICALS PRIVATE LIMITED

Director

06/02/2004

06/02/2004

-

Active

NO

5

U24231MH1994PTC079977

GENOME PHARMACEUTICALS AND CHEMICALS PRIVATE LIMITED

Director

06/02/2004

06/02/2004

-

Active

NO

6

U24230MH2004PLC148151

VIDA MEDICAREZ LIMITED

Director

20/08/2004

20/08/2004

-

Active

NO

7

U52520MH2001PTC130447

ONE-STOP SHOP INDIA PRIVATE LIMITED

Director

11/02/2007

11/02/2007

-

Active

NO

8

U45200MH2007PLC174288

BHAKTI ENTERPRISES LIMITED

Director

19/09/2007

19/09/2007

-

Active

NO

9

U45400WB2008PTC123608

BHUBANESWAR PROJECTS PRIVATE LIMITED

Director

05/03/2008

05/03/2008

-

Active

NO

10

U45200MH2002PTC137631

SHREE MADHUR REALTORS PRIVATE LIMITED

Additional director

19/08/2009

19/08/2009

23/04/2011

Active

NO

11

U70102MH2009PTC195001

KIMAYA PROPERTY PRIVATE LIMITED

Director

30/09/2010

01/07/2010

-

Active

NO

12

U93030MH2011PTC223159

AMRITA IMPEX PRIVATE LIMITED

Director

17/10/2011

17/10/2011

-

Active

NO

13

U93030MH2011PTC223440

CHAKRA MERCANTILE PRIVATE LIMITED

Director

25/10/2011

25/10/2011

-

Active

NO

14

U93030MH2011PTC223781

PUNYA EXIM PRIVATE LIMITED

Director

11/11/2011

11/11/2011

-

Active

NO

 

 

Name :

Mr. Pankaj Nandkishor Chandak

Designation :

Whole-time director

Address :

502, A Wing, The Crest, Rahatani Road, Pune – 411027, Maharashtra, India

Date of Birth/Age :

08.10.1980

Qualification :

B. Com

Date of Appointment :

01.04.2011

PAN No.:

AGFPC5280M

DIN No.:

03015380

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24239MH1992PLC065031

AGIO PHARMACEUTICALS LIMITED

Whole-time director

01/04/2011

19/04/2010

Active

NO

2

U24230MH2004PLC148151

VIDA MEDICAREZ LIMITED

Director

30/09/2010

20/08/2010

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 29.09.2012

 

Names of Shareholders

 

No. of Shares

 

Madhusudan Ruia

 

1360035

Sanjay Ruia

 

25

Sita Ruia

 

1126265

Sangeeta Sanjay Ruia

 

250000

Madhusudan G. Ruia (HUF)

 

545093

Sanjay G. Ruia (HUF)

 

102890

Ritika .M. Ruia

 

71087

Shree Madhur Realtors, India

 

1125000

Emfor International, UAE

 

516865

Rishabh M. Ruia

 

71038

Govindprasad Ruia (HUF)

 

16468

 

 

 

Total

 

5184766

 

 

AS ON 29.09.2012

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

16.78

Bodies corporate

 

21.70

Directors or relatives of directors

 

61.52

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Prescription Drugs.

 

 

Products/ Services :

ITC Code No.

Product Descriptions

30042033

Bottle

30041090

Tubes

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

¯      HDFC Bank Limited

¯      Union Bank of India, Mumbai Samachar Marg Branch, 66/80, Mumbai Samachar Marg, Fort, Mumbai - 400023, Maharashtra, India

¯      The Cosmos Co-operative Bank Limited, 269/270, Cosmos Heights, Pune, Pune - 411030, Maharashtra, India

¯      The Cosmos Co-operative Bank Limited, 101, 1st Floor, Pratik Avenue, Nehru Road, Vileparle (East), Mumbai - 411030, Maharashtra, India

¯      Oriental Abnk of Commerce, Overseas Branch, Nariman Point, Mumbai, Maharashtra, India

¯      State Bank of India, Industrial Finance Brnch, Sakinaka, Mumbai - 400072, Maharashtra, India

¯      State Bank of India, Mid Corporate Loan Administration Unit, R T O Lane, Andheri (West), Mumbai - 400053, Maharashtra, India

 

 

Facilities :

 

Secured Loans

31.03.2012

31.03.2011

 

 

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

95.148

134.505

Loans taken for fixed assets

9.105

16.429

SHORT-TERM BORROWINGS

 

 

Working capital loans from banks

425.049

402.676

Total

529.302

553.610

 

Note:

 

LONG-TERM BORROWINGS

Indian Rupee Loan from Bank Includes Vehicle Loan of Rs. 1.662 Millions from HDFC Bank which are Secured against the respective Vehicles. Indian Rupee Loan from Union Bank of India carries a Interest Rate of 16.25% p.a. , Indian Rupee Loan from The Cosmos Co-op Bank Limited Carries a Interest load of 11.00% p.a. Loan from Financial Institution include vehicle Loans of Rs. 7.443 Millions from Kotak Mahindra Prime Limited which are Secured against Respective Vehicles Loan From Religare Finvest Limited is Secured against personal Assets of Directors. Out of the above, Term Loans aggregating to Rs. 95.147 Millions and Working Capital facilities aggregating to Rs. 408.333 Millions are secured by equitable mortgage/hypothecation in favour of Union Bank of India and The Cosmos Co-op Bank Limited on Pari Pasu basis on following Assets : Prime Securities 1 Equitable Mortgage of Land and Building situated at T-81 and T-82, MIDC, Bhosari, Pune. 2 Hypothecation of Plant and Machinery situated at T-81 and T-82 and entire Current Assets of the Company. Collateral Securities 3 Equitable Mortgage of Industrial Gala A-38 and A-39 situated at Andheri are standing in the names of Revive Pharmaceuticals Private Limited and Genome Pharmaceuticals and Chemicals Private Limited respectively. 4 Equitable Mortgage of Residential Flat No. 2001 A/B and 2002, Norita, Hiranandani Gardens, Powai, Mumbai standing in the name of Smt. Sita Ruia. 5 Personal Gurantee of Managing Director Shri. Madhsudan Ruia and Smt Sita Ruia. 6 Corporate Guarantee of Revive Pharmaceuticals Private Limited and Genome Chemical and Pharmaceuticals Private Limited Following securities will remain exclusively for The cosmos Co-operative Bank Limited:- 1 Industrial Gala No. A-37, Nandjyot Industrial Estate, Safed Pool, Kurla Andheri Road, situated at Andheri is standing in the name of Bhakti Enterprises Limited. 2 Flat No. C-602, Mayur Panorama, CTS No. 6011, Pimpri Village, situated at Pune is standing in the name of Shree Madhur Realtors Private Limited. Following securities will remain exclusively for Union Bank of India :- 1 Gala No. 4,5 and 8 Natha Compound, Rahnal, Bhiwandi are standing in the name of Shree Madhur Realtors Private Limited. 2 Gala No. 3 Natha Compound, Rahnal, Bhiwandi is standing in the name of Bhakti Enterprises Limited. 3 Pledge of 5000 Shares of NIIT Technologies Limited and 1700 Shares of Indian Oil Corporation Standing in the name of Ms. Ritika M Ruia. 4 Equipments/ Machineries to be purchased out of Term Loan III.

 

Indian Rupee Loan from Bank Includes Vehicle Loan of Rs. 1.662 Millions from HDFC Bank which are Secured against the respective Vehicles. Loan from Financial Institution include vehicle Loans of Rs. 7.443 Millions from Kotak Mahindra Prime Limited which are Secured against Respective Vehicles

 

 

SHORT-TERM BORROWINGS

Out of the above, Term Loans aggregating to Rs. 95.147 Millions and Working Capital facilities aggregating to Rs. 408.333 Millions are secured by equitable mortgage/hypothecation in favour of Union Bank of India and The Cosmos Co-op Bank Limited on Pari Pasu basis on following Assets: Prime Securities 1 Equitable Mortgage of Land and Building situated at T-81 and T-82, MIDC, Bhosari, Pune. 2 Hypothecation of Plant and Machinery situated at T-81 and T-82 and entire Current Assets of the Company. Collateral Securities 3 Equitable Mortgage of Industrial Gala A-38 and A-39 situated at Andheri are standing in the names of Revive Pharmaceuticals Private Limited and Genome Pharmaceuticals and Chemicals Private Limited respectively. 4 Equitable Mortgage of Residential Flat No. 2001 A/B and 2002, Norita, Hiranandani Gardens, Powai, Mumbai standing in the name of Smt. Sita Ruia. 5 Personal Gurantee of Managing Director Shri. Madhsudan Ruia and Smt Sita Ruia. 6 Corporate Guarantee of Revive Pharmaceuticals Private Limited and Genome Chemical and Pharmaceuticals Private Limited Following securities will remain exclusively for The cosmos Co-operative Bank Limited:- 1 Industrial Gala No. A-37, Nandjyot Industrial Estate, Safed Pool, Kurla Andheri Road, situated at Andheri is standing in the name of Bhakti Enterprises Limited. 2 Flat No. C-602, Mayur Panorama, CTS No. 6011, Pimpri Village, situated at Pune is standing in the name of Shree Madhur Realtors Private Limited. Following securities will remain exclusively for Union Bank of India :- 1 Gala No. 4,5 and 8 Natha Compound, Rahnal, Bhiwandi are standing in the name of Shree Madhur Realtors Private Limited. 2 Gala No. 3 Natha Compound, Rahnal, Bhiwandi is standing in the name of Bhakti Enterprises Limited. 3 Pledge of 5000 Shares of NIIT Technologies Limited and 1700 Shares of Indian Oil Corporation Standing in the name of Ritika M Ruia. 4 Equipments/Machineries to be purchased out of Term Loan III.

 

 

 

 

Banking Relations :

--

 

 

Financial Institutions :

¯      Kotak Mahindra Prime Limited

¯      Religare Finvest Limited

 

 

Auditors :

 

Name :

Banka and Banka

Chartered Accountants

Address :

3rd Floor, Shah Trade Center, Rani Sati Marg, Off Western Express Highway, Malad (East), Mumbai – 400097, Maharashtra, India

Tel. No.:

91-22-40984545

E-Mail :

info@bankabanka.com  

Website :

www.bankabanka.com

Income-tax PAN of auditor or auditor's firm :

AAAFB1145R

 

 

Enterprises which are owned, or have significant influence of or are partners

with Key management personnel and their relatives :

¯      Lifesource Healthcare

¯      Rank International

¯      Shree Print and Pack

 

 

 

Related Companies:

¯      Genome Pharmaceuticals and Chemical Private Limited

¯      Revive Pharmaceuticals Limited

¯      Shree Madhur Realtors Private Limited

¯      Bhakti Enterprise Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6,000,000

Equity Shares

Rs. 10/- each

Rs. 60.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,184,766

Equity Shares

Rs. 10/- each

Rs. 51.848 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

51.848

50.083

(b) Reserves & Surplus

 

365.593

322.531

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

417.441

372.614

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

445.596

378.804

(b) Deferred tax liabilities (Net)

 

15.770

9.664

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

461.366

388.468

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

425.049

402.676

(b) Trade payables

 

376.449

290.910

(c) Other current liabilities

 

41.019

24.178

(d) Short-term provisions

 

8.465

8.356

Total Current Liabilities (4)

 

850.982

726.120

 

 

 

 

TOTAL

 

1729.789

1487.202

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

330.873

348.334

(ii) Intangible Assets

 

62.550

15.233

(iii) Capital work-in-progress

 

2.966

3.103

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.621

0.611

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

40.014

52.636

(e) Other Non-current assets

 

23.676

20.460

Total Non-Current Assets

 

460.700

440.377

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

246.003

290.559

(c) Trade receivables

 

812.512

557.026

(d) Cash and cash equivalents

 

10.930

9.680

(e) Short-term loans and advances

 

199.457

189.457

(f) Other current assets

 

0.187

0.103

Total Current Assets

 

1269.089

1046.825

 

 

 

 

TOTAL

 

1729.789

1487.202

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

50.083

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

309.061

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

359.144

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

392.246

2] Unsecured Loans

 

 

152.971

TOTAL BORROWING

 

 

545.217

DEFERRED TAX LIABILITIES

 

 

11.167

 

 

 

 

TOTAL

 

 

915.528

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

390.544

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.510

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 

240.964

 

Sundry Debtors

 
 

415.301

 

Cash & Bank Balances

 
 

12.197

 

Other Current Assets

 
 

0.000

 

Loans & Advances

 
 

155.320

Total Current Assets

 
 

823.782

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

 
 

219.409

 

Other Current Liabilities

 
 

75.884

 

Provisions

 
 

4.309

Total Current Liabilities

 
 

299.602

Net Current Assets

 
 

524.180

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.294

 

 

 

 

TOTAL

 

 

915.528

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Revenue from operations

1912.425

1389.189

981.413

 

 

Other Income

0.000

0.000

3.446

 

 

TOTAL                                     (A)

1912.425

1389.189

984.859

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of materials consumed

1343.334

918.105

 

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

24.599

(34.019)

 

 

 

Employee benefit expense

127.609

147.557

 

 

 

Other expenses

217.325

208.846

 

 

 

Exceptional items

0.851

0.262

 

 

 

TOTAL                                     (B)

1713.718

1240.751

837.888

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

198.707

148.438

146.971

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

101.600

71.597

73.662

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

97.107

76.841

73.309

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

60.111

54.822

53.050

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

36.996

22.019

20.259

 

 

 

 

 

Less

TAX                                                                  (H)

6.567

7.965

7.486

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

30.429

14.054

12.773

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

187.232

173.762

161.575

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

0.518

0.501

0.501

 

 

Corporate Dividend Tax thereon

0.084

0.083

0.085

 

BALANCE CARRIED TO THE B/S

217.059

187.232

173.762

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

836.274

528.357

432.935

 

 

 

 

 

 

VALUE OF IMPORT ON CIF BASIS

202.814

43.096

25.983

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

Basic

5.87

2.81

2.39

 

Diluted

6.03

2.81

2.21

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

1.59

1.01

1.30

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

1.93

1.59

2.06

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.14

1.48

1.67

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.09

0.06

0.06

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

2.09

2.10

1.52

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.49

1.44

2.75

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOANS

 

Unsecured Loans

31.03.2012

31.03.2011

 

 

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

76.554

72.217

Deposits from shareholders

107.089

83.998

Loans and advances from related parties

69.720

0.000

Other loans and advances

87.980

71.655

Total

341.343

227.870

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24239MH1992PLC065031

Name of the company

AGIO PHARMACEUTICALS LIMITED

Address of the registered office or of the principal place of  business in India of the company

A-38, Nandjyot Industrial Estate, Kurla Andheri Road, Safedpool, Andheri (East), Mumbai – 400072, Maharashtra, India

Email: sdarjee@agio-pharma.com

This form is for

Modification of charge

Charge identification number of the modified 

10286381

Type of charge

Immovable property

Book debts

Movable property (not being pledge)

Floating charge

Particular of charge holder

The Cosmos Co-operative Bank Limited, 269/270, Cosmos Heights, Pune, Pune - 411030, Maharashtra, India

Email: aakanksha.rane@cosmosbank.in

Nature of description of the instrument creating or modifying the charge

Memorandum of Understanding dated 22nd March, 2013

Date of instrument Creating the charge

22.03.2013

Amount secured by the charge

Rs. 302.000 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

1) Cash Credit - 13.00% p.a. as per present credit rating, 2) Letter of Credit - Commission as per Banks Rules

 

Terms of Repayment

Cash Credit - repayable on demand/ review within 12 months

Export Packing Credit - repayable on demand/ review within 12 months

Foreign Bills Discounting - repayable on demand/ review within 12 months

Letter of Credit - review within 12 months

Bank Guarantee - as per Bank Guarantee terms/ review within 12 months

LER Limit for forward cover booking - review within 12 months

 

Margin

Cash Credit - 25%

Export Packing Credit - 10%

Foreign Bills Discounting - 10%

Letter of Credit - 10%

Bank Guarantee - 10%

LER Limit for forward cover booking - 10%

 

Extent and Operation of the charge

Cash Credit - Pari Passu charge on all current assets with UBI

Export Packing Credit - Pari Passu charge on all current assets with UBI 

Foreign Bills Discounting - Foreign bills to be discounted

Letter of Credit - Raw material to be purchased under LC

Bank Guarantee - Cash Margin, extended charge on the current and/or fixed assets

LER Limit for forward cover booking - Pari Passu Charge on stock and debtors with UBI and extended charge on the collateral securities offered to other existing limits

 

Short particulars of the property charged

Land and Building situated at Plot No.T-81 and T-82, MIDC, Bhosari, Pune owned by Agio Pharmaceuticals Limited on pari passu basis with UBI,

 

Hypothecation charge on plant and machinery and other fixed assets situated at Plot No.T-81 and T-82, MIDC, Bhosari, Pune owned by Agio Pharmaceuticals Limited on pari passu basis with UBI,

 

Gala No. A/38, Nand-Jyot Indl Estate, Safed Pool, Kurla-Andheri Road, Mumbai - 400072 owned by Revive Pharmaceuticals Private Limited on pari passu basis with UBI,

 

Gala No. A/39, Nand-Jyot Indl Estate, Safed Pool, Kurla-Andheri Road, Mumbai - 400072 owned by Genome Pharmaceuticals and Chemicals Private Limited on pari passu basis with UBI,

 

Residential Flat No.2001 A/B and 2002, Norita, Hiranandani Garden, Powai, Mumbai belonging to Mrs Sita Ruia on pari passu basis with UBI,

 

Gala No. A/37, Nand-Jyot Indl Estate, Safed Pool, Kurla-Andheri Road, Mumbai - 400072 belonging to Bhakti Enterprises Limited, exclusively with Cosmos Bank,

 

Flat No. C-602 situated in the Building Mayur Panorama, CTS No. 6011, Village Pimpri Waghire, Pune belonging to Shree Madhur Realtors Private Limited exclusively with Cosmos Bank.

Particulars of the present modification 

Existing charge modified from Rs. 307.000 Millions to Rs.302.000 Millions consist of:

1) Cash Credit Rs.225.000 Millions

Sub limit A Export Packing Credit Rs.112.500 Millions

Sub limit B Foreign Bill Discounting limit Rs.112.500 Millions

2) Letter of credit Rs.65.000 Millions - Out of the LC limit of Rs.65.000 Millions, the Company can utilise Rs.25.000 Millions interchangeable with Cash Credit Limit. thus, the total utilization of CC & LC will not exceed Rs. 290.000 Millions.

Sub limit A Bank Guarantee - Rs.12.500 Millions

3) LER Limit - Rs.12.000 Millions

 

 

FIXED ASSETS:

 

¯      Land

¯      Buildings

¯      Factory building

¯      Plant and equipment

¯      Factory equipments

¯      Furniture and fixtures

¯      Vehicles

¯      Motor vehicles

¯      Office equipment

¯      Computer equipments

¯      Other equipments


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 59.36

UK Pound

1

Rs. 86.69

Euro

1

Rs. 77.99

 

 

INFORMATION DETAILS

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.